Rising HSA limits and higher Medicare premiums in 2026 could lift demand for chronic care devices from DexCom, ResMed and Masimo.
Source: https://www.zacks.com/stock/news/2810011/3-stocks-likely-to-…
Will they or won’t they? Stocks have moved higher in the last quarter of 2025 as the Federal Reserve started to cut interest rates.
Alphabet should continue to benefit from a strong AI tailwind in 2026. Vertex Pharmaceuticals has several growth drivers in the new year.
The 8 “big and rich” tech stocks ARE the stock market (37% of the S&P 500), but indexation reduces long-term stock-picking value. My technical analysis of these is thus for shorter-term, tactical trading, viewing the giants as too overvalued for long-term holding.
